Radio and PodcastRadio and PodcastLive Radio & Podcasts
149 - Neulasta biosimilar; Leukine for acute radiation syndrome; priority review for Hemlibra; FDA Office of New Drug reorganization artwork
Science & Medicine

149 - Neulasta biosimilar; Leukine for acute radiation syndrome; priority review for Hemlibra; FDA Office of New Drug reorganization

New FDA Approvals

Jun 7, 201812:15Science & Medicine

149 - Neulasta biosimilar; Leukine for acute radiation syndrome; priority review for Hemlibra; FDA Office of New Drug reorganization is an episode from New FDA Approvals. This science & medicine episode is made for liste...

About This Episode

149 - Neulasta biosimilar; Leukine for acute radiation syndrome; priority review for Hemlibra; FDA Office of New Drug reorganization is an episode from New FDA Approvals. This science & medicine episode is made for listeners who follow New...

Podcast

This episode belongs to New FDA Approvals.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Jun 7, 2018, 12:15 long, audio available.